Also known as: galactokinase deficiency screening, GALK screening.

What is galactokinase?

Galactokinase is a common enzyme in the body that facilitates the metabolism of the sugar galactose found in dairy and some fruits and vegetables. When the body is deficient in galactokinase (a recessively inherited genetic disorder) it causes galactose and galactitol to build up in the body. Galactokinase is one of 3 inborn inherited errors of metabolism that lead to high blood levels of galactose (and one type of a group of disorders called galactosemia). In the newborn baby it presents primarily with the early onset of bilateral eye cataracts as a result of galactitol accumulating in the lens of the eye. The newborn blood screening test examines for the blood level of galactokinase which usually will identify a deficiency.

What happens during the procedure?

Blood is drawn either by routine heel prick or from a vein after birth as part of the newborn screening for inborn errors of metabolism (or later as appropriate) which is sent to a laboratory for testing.

Is any special preparation needed? 

In most cases, no special preparation is needed for the test.

What are the risk factors?

Pain, bleeding, infection and damage to surrounding organs and tissues (depending on how blood is drawn) are potential risks.

Reviewed by: Jack Wolfsdorf, MD, FAAP

This page was last updated on: 8/23/2018 8:51:02 AM

From the Newsdesk

Nicklaus Children's Hospital to offer new rapid genetic test
Nicklaus Children's Hospital will be one of a handful in the country to offer a fast turn-around on genome sequencing that can be a key to saving infants with rare and hard-to-diagnose genetic disorders. As seen on The Miami Herald.
Research Study: How your child's genetic makeup can impact the way he or she responds to certain medications
Enzymes are particularly important in the processing of medicines and drugs. They determine how our bodies are going to handle the medicines we take, and if those medicines are going to help us feel better or not. This research study includes testing the status of the CYP2D6 gene in children.